Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget’s disease of bone

Author： Polyzos Stergios

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.30, Iss.1, 2011-01, pp. : 149-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

SQSTM1 and Paget’s Disease of Bone

By Layfield R.

Calcified Tissue International, Vol. 75, Iss. 5, 2004-11 ,pp. : 347-357

Springer Publishing Company

Access to resources Recommend Favorite

Risedronate and Pamidronate Treatment in the Clinical Management of Patients with Severe Paget’s Disease of Bone and Acquired Resistance to Bisphosphonates

By Rendina D.

Calcified Tissue International, Vol. 75, Iss. 3, 2004-09 ,pp. : 189-196

Springer Publishing Company

Access to resources Recommend Favorite

Paget’s Disease of Bone in New Zealand: Continued Decline in Disease Severity

By Cundy H.

Calcified Tissue International, Vol. 75, Iss. 5, 2004-11 ,pp. : 358-364

Springer Publishing Company

Access to resources Recommend Favorite

1st European Conference on Paget’s Disease of Bone

Calcified Tissue International, Vol. 75, Iss. 3, 2004-09 ,pp. : 263-273

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Determinants of Quality of Life in Paget’s Disease of Bone

By Langston A. Campbell M. Fraser W. MacLennan G. Selby P. Ralston S.

Calcified Tissue International, Vol. 80, Iss. 1, 2007-01 ,pp. : 1-9

Springer Publishing Company

Access to resources Recommend Favorite